BLKB vs SRPT · P/E 9.1, rev $1.16B vs rev $1.90B
Blackbaud Inc (BLKB) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Blackbaud Inc (BLKB) is a software - application company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported BLKB revenue for 2024-12-31 was $1.16B. Net income was -$283.2M. Revenue was up 4.5% from 2023-12-31 to 2024-12-31. BLKB currently screens at market cap $1.23B and trailing P/E 9.1.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
BLKB currently screens at market cap $1.23B and trailing P/E 9.1. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the BLKB and SRPT stock pages for the full models.
Not investment advice.